Wang Yaran, Wu Fan, Ren Yijin, Liu Yong, Mei Henny C
State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Functional Polymer Materials, Ministry of Education, Institute of Polymer Chemistry, College of Chemistry, Nankai University, Tianjin 300071, China.
Department of Biomaterials and Biomedical Technology, University of Groningen and University Medical Center Groningen, Groningen, Netherlands.
Research (Wash D C). 2025 Aug 21;8:0853. doi: 10.34133/research.0853. eCollection 2025.
Bacterial infections pose a major challenge today due to the rise of drug resistance in pathogenic bacteria, creating an urgent need for the development of nonantibiotic therapies. Metal nanomaterials are increasingly recognized as promising antibacterial agents due to their unique physical and chemical properties, which offer strong antibacterial capabilities and broad-spectrum activity against drug-resistant bacteria. Unlike traditional antibacterial therapies, metal nanomaterials rarely induce drug resistance because of their diverse antibacterial mechanisms, which destroy bacteria by directly damaging bacterial cells or generating oxidative stress. Metal nanomaterials have proven effective in treating various drug-resistant bacterial infections. This perspective highlights recent advances in metal nanomaterials for antimicrobial applications. Firstly, bacterial infections and the current dilemma are introduced. Next, recent progress in the antibacterial activity of metal nanomaterials against drug-resistant bacteria is summarized, along with the challenges in their antimicrobial applications. Finally, future prospects and remaining challenges associated with the use of metal nanomaterials to treat drug-resistant bacteria are discussed.
由于致病细菌耐药性的上升,细菌感染如今构成了一项重大挑战,这使得开发非抗生素疗法变得迫切。金属纳米材料因其独特的物理和化学性质而越来越被视为有前景的抗菌剂,这些性质赋予了强大的抗菌能力以及针对耐药细菌的广谱活性。与传统抗菌疗法不同,金属纳米材料很少诱导耐药性,因为它们具有多种抗菌机制,通过直接破坏细菌细胞或产生氧化应激来消灭细菌。金属纳米材料已被证明在治疗各种耐药细菌感染方面有效。这篇综述强调了金属纳米材料在抗菌应用方面的最新进展。首先,介绍了细菌感染及当前的困境。接下来,总结了金属纳米材料对耐药细菌抗菌活性的最新进展以及它们在抗菌应用中的挑战。最后,讨论了使用金属纳米材料治疗耐药细菌的未来前景和 remaining challenges。(注:原文中“remaining challenges”未翻译完整,推测可能是“剩余挑战”之类的表述)
Research (Wash D C). 2025-8-21
2025-1
Arch Ital Urol Androl. 2025-6-30
Research (Wash D C). 2025-4-16
Antibiotics (Basel). 2025-2-18
Drug Resist Updat. 2024-11
BME Front. 2023-4-24